13-52010642-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000053.4(ATP7B):​c.51+645A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.634 in 152,078 control chromosomes in the GnomAD database, including 32,233 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.63 ( 32233 hom., cov: 33)

Consequence

ATP7B
NM_000053.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -4.84

Publications

4 publications found
Variant links:
Genes affected
ATP7B (HGNC:870): (ATPase copper transporting beta) This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019]
ATP7B Gene-Disease associations (from GenCC):
  • Wilson disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000053.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.74 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000053.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP7B
NM_000053.4
MANE Select
c.51+645A>G
intron
N/ANP_000044.2P35670-1
ATP7B
NM_001406511.1
c.51+645A>G
intron
N/ANP_001393440.1P35670-1
ATP7B
NM_001406512.1
c.51+645A>G
intron
N/ANP_001393441.1P35670-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP7B
ENST00000242839.10
TSL:1 MANE Select
c.51+645A>G
intron
N/AENSP00000242839.5P35670-1
ATP7B
ENST00000634844.1
TSL:1
c.51+645A>G
intron
N/AENSP00000489398.1B7ZLR4
ATP7B
ENST00000418097.7
TSL:1
c.51+645A>G
intron
N/AENSP00000393343.2F5H748

Frequencies

GnomAD3 genomes
AF:
0.634
AC:
96338
AN:
151960
Hom.:
32217
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.406
Gnomad AMI
AF:
0.601
Gnomad AMR
AF:
0.687
Gnomad ASJ
AF:
0.729
Gnomad EAS
AF:
0.595
Gnomad SAS
AF:
0.555
Gnomad FIN
AF:
0.746
Gnomad MID
AF:
0.713
Gnomad NFE
AF:
0.746
Gnomad OTH
AF:
0.682
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.634
AC:
96383
AN:
152078
Hom.:
32233
Cov.:
33
AF XY:
0.634
AC XY:
47174
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.406
AC:
16831
AN:
41450
American (AMR)
AF:
0.686
AC:
10487
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.729
AC:
2530
AN:
3472
East Asian (EAS)
AF:
0.595
AC:
3074
AN:
5164
South Asian (SAS)
AF:
0.554
AC:
2677
AN:
4828
European-Finnish (FIN)
AF:
0.746
AC:
7897
AN:
10582
Middle Eastern (MID)
AF:
0.719
AC:
210
AN:
292
European-Non Finnish (NFE)
AF:
0.746
AC:
50687
AN:
67980
Other (OTH)
AF:
0.683
AC:
1442
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1671
3341
5012
6682
8353
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
778
1556
2334
3112
3890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.688
Hom.:
13303
Bravo
AF:
0.622
Asia WGS
AF:
0.574
AC:
1993
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.68
DANN
Benign
0.61
PhyloP100
-4.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs7321120;
hg19: chr13-52584778;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.